Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1
5-Year Impact Factor – 2.2
Scopus CiteScore – 3.4 (CiteScore Tracker 3.7)
Index Copernicus  – 161.11; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2020, vol. 29, nr 7, July, p. 887–892

doi: 10.17219/acem/76750

Publication type: original article

Language: English

License: Creative Commons Attribution Non-Commercial License

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Risk factors of recurrence and poor survival in curatively resected hepatocellular carcinoma with microvascular invasion

Li Zhou1,A,B,C,D,E,F, Shao-Bin Wang1,B, Shu-Guang Chen1,B, Qiang Qu1,C, Jing-An Rui1,C,D,E

1 Department of General Surgery, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China

Abstract

Background. Microvascular invasion (MVI) is a significant sign of the invasive property and a strong predictor of poor prognosis in hepatocellular carcinoma (HCC), a life-threatening malignancy. However, recurrence-associated and post-surgical long-term prognosis-associated factors in HCC with MVI remain unknown.
Objectives. To address the abovementioned issues, based on a Chinese patient cohort with HCC after curative hepatic resection.
Material and Methods. The patient cohort consisted of 62 consecutive patients with HCC and MVI who underwent curative hepatic resection. The associations between clinicopathologic variables and recurrence, as well as patient overall/disease-free survival, were uniand multivariately evaluated.
Results. Univariate χ2 test identified hepatitis B surface antigen (HBsAg) positivity, high Edmondson–Steiner grade and male gender as risk factors of recurrence, whereas Edmondson–Steiner grade and HBsAg positivity were significant or marginally significant in the multivariate stepwise logistic regression analysis. Subsequently, univariate log-rank test showed that Edmondson–Steiner grade, HBsAg positivity and Child–Pugh grade were associated with overall and/or disease-free survival. Among them, the independent prognostic impact of Edmondson–Steiner grade and HBsAg positivity for both overall and disease-free survival were proven in the multivariate Cox regression analysis.
Conclusion. Our data suggested that Edmondson–Steiner grade and HBsAg positivity might serve as useful indicators of recurrence and pessimistic prognosis in HCC with MVI.

Key words

prognostic factor, recurrence, survival, hepatocellular carcinoma, hepatic resection

References (28)

  1. Pisani P, Parkin DM, Bray F, Ferlay J. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94(2):153–156.
  2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.
  3. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
  4. Tandon P, Garcia-Tsao G. Prognostic indicators in hepatocellular carcinoma: A systematic review of 72 studies. Liver Int. 2009;29(4):502–510.
  5. Ng KM, Yan TD, Black D, Chu FC, Morris DL. Prognostic determinants for survival after resection/ablation of a large hepatocellular carcinoma. HPB (Oxford). 2009;11(4):311–320.
  6. Belli G, Fantini C, Belli A, Limongelli P. Laparoscopic liver resection for hepatocellular carcinoma in cirrhosis: Long-term outcomes. Dig Surg. 2011;28(2):134–140.
  7. Bertuzzo VR, Cescon M, Ravaioli M, et al. Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. Transplantation. 2011;91(11):1279–1285.
  8. Lim KC, Chow PK, Allen JC, et al. Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria. Ann Surg. 2011;254(1):108–113.
  9. Fan ST, Poon RT, Yeung C, et al. Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria. Br J Surg. 2011; 98(9):1292–1300.
  10. Adam R, Bhangui P, Vibert E, et al. Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: Does size define the best oncological strategy? Ann Surg. 2012;256(6):883–891.
  11. Shindoh J, Hasegawa K, Inoue Y, et al. Risk factors of post-operative recurrence and adequate surgical approach to improve long-term outcomes of hepatocellular carcinoma. HPB (Oxford). 2013;15(1):31–39.
  12. Abdel-Wahab M, Sultan AM, Fathy OM, et al. Factors affecting recurrence and survival after living donor liver transplantation for hepatocellular carcinoma. Hepatogastroenterology. 2013;60(128):1847–1853.
  13. Li SH, Wei W, Guo RP, et al. Long-term outcomes after curative resection for patients with macroscopically solitary hepatocellular carcinoma without macrovascular invasion and an analysis of prognostic factors. Med Oncol. 2013;30(4):696.
  14. Zhao H, Chen C, Fu X, et al. Prognostic value of a novel risk classification of microvascular invasion in patients with hepatocellular carcinoma after resection. Oncotarget. 2017;8(3):5474–5486.
  15. Zheng J, Kuk D, Gönen M, et al. Actual 10-year survivors after resection of hepatocellular carcinoma. Ann Surg Oncol. 2017;24(5):1358–1366.
  16. Edmondson HA, Steiner PE. Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer. 1954;7(3):462–503.
  17. Zhou L, Rui JA, Wang SB, Chen SG, Qu Q. The significance of serum AFP cut-off values, 20 and 400 ng/mL in curatively resected patients with hepatocellular carcinoma and cirrhosis might be of difference. Hepatogastroenterology. 2012;59(115):840–843.
  18. Zhou L, Rui JA, Wang SB, Chen SG, Qu Q. Risk factors of poor prognosis and portal vein tumor thrombosis after curative resection of solitary hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2013; 12(1):68–73.
  19. Jeng KS, Sheen IS, Tsai YC. Circulating messenger RNA of alpha-fetoprotein: A possible risk factor of recurrence after resection of hepatocellular carcinoma. Arch Surg. 2004;139(10):1055–1060.
  20. Qu LS, Jin F, Huang XW, Shen XZ. High hepatitis B viral load predicts recurrence of small hepatocellular carcinoma after curative resection. J Gastrointest Surg. 2010;14(7):1111–1120.
  21. Xia F, Lai EC, Lau WY, et al. High serum hyaluronic acid and HBV viral load are main prognostic factors of local recurrence after complete radiofrequency ablation of hepatitis B-related small hepatocellular carcinoma. Ann Surg Oncol. 2012;19(4):1284–1291.
  22. Zhou L, Rui JA, Zhou WX, Wang SB, Chen SG, Qu Q. Edmondson–Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasion. Pathol Res Pract. 2017;213(7):824–830.
  23. Peng SY, Chen WJ, Lai PL, Jeng YM, Sheu JC, Hsu HC. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: Significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Int J Cancer. 2004;112(1):44–50.
  24. Pardee AD, Shi J, Butterfield LH. Tumor-derived α-fetoprotein impairs the differentiation and T cell stimulatory activity of human dendritic cells. J Immunol. 2014;193(11):5723–5732.
  25. Lu Y, Zhu M, Li W, et al. Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells. J Cell Mol Med. 2016;20(3):549–558.
  26. Xiangji L, Feng X, Qingbao C, et al. Knockdown of HBV surface antigen gene expression by a lentiviral microRNA-based system inhibits HBV replication and HCC growth. J Viral Hepat. 2011;18(9):653–660.
  27. Peng ZW, Chen MS, Liang HH, et al. A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. Eur J Surg Oncol. 2010;36:257–263.
  28. Liu XY, Xu JF. Liver resection for young patients with large hepatocellular carcinoma: A single center experience from China. World J Surg Oncol. 2014;12:175.